Vitamin K2 MK7 (menaquinone-7) and MK4 (menaquinone-4) are two forms of the same vitamin family. MK7 stays detectable in the blood longer, while MK4 has a different tissue and clinical research history; that difference does not make one a universal winner for bone or cardiovascular health.
A useful comparison addresses three questions. How does the form move through your body, what did human studies measure, and does the complete product fit your health history?
Key Takeaways
The Short Version
MK7 and MK4 support vitamin K-dependent proteins, but their blood kinetics differ.
Longer blood availability does not automatically mean better fracture or cardiovascular outcomes.
Human bone studies on MK7 have reported both favorable findings and null results.
Vitamin K supplements require special review if you take a vitamin K antagonist such as warfarin.
Quick Comparison of MK7 and MK4
MK7 has a clearer advantage in sustained blood availability, while a clinical outcome comparison requires more context. This table separates the form, the research, and the buying decision.
| Factor | MK7 | MK4 | Practical Meaning |
|---|---|---|---|
| Vitamin family | Menaquinone-7, a form of K2 | Menaquinone-4, a form of K2 | K2 alone does not identify the form. |
| Food context | Found mainly in natto (fermented soybeans) and other fermented foods | Found in animal foods and body tissues | Dietary sources differ. |
| Blood availability | More sustained in comparative human research | Less detectable in the same nutritional study | Blood levels answer a kinetics question. |
| Bone research | Several trials in postmenopausal women, with mixed outcomes | Menatetrenone studies in specific clinical settings | Compare populations and outcomes before ranking. |
| Medication review | Interacts with vitamin K antagonist therapy | Also requires review with vitamin K antagonists | Switching forms is not an interaction workaround. |
The food and blood-availability distinctions are described in a comparative study in healthy Japanese women. MK7 stayed measurable in the blood for up to two days after a single dose and built up with daily intake, while MK4 at a nutritional dose did not show up in the blood at all. That staying power is a big part of why MK7 appears so often on supplement labels.
What the Numbers in MK7 and MK4 Mean
The numbers describe the side chain attached to the vitamin’s shared chemical structure. MK7 has seven repeating units in that chain, while MK4 has four.
That structural difference affects how the molecules are handled. Both belong to vitamin K2, also called the menaquinone family, and both participate in the vitamin K system.
Vitamin K helps activate proteins through a process called carboxylation. In plain language, this chemical modification allows certain proteins to do their normal jobs.
Osteocalcin, a protein associated with bone, is one example of a protein that needs vitamin K. Matrix Gla protein, found in vascular tissues, is another; the biology explains why vitamin K comes up in bone and cardiovascular support, but clinical outcomes still need to be measured.
For a wider view of supplement evidence on a range of supplements, read our longevity supplement guide. Different compounds can share healthy-aging goals.
Why MK7 Stays in the Blood Longer
MK7 produces more sustained measurable blood levels than MK4 in a small comparative human study.
In the 2012 study by Sato and colleagues, researchers compared the forms in healthy Japanese women. MK7 was measurable after intake and accumulated with repeated intake, while MK4 did not show the same serum pattern under the tested conditions.
The study measured circulating vitamin, not fractures, heart attacks, or how each tissue used each form. Low blood detectability doesn’t mean that MK4 has no biological role.
Likewise, longer persistence does not guarantee superior performance. A form can change a blood measurement without delivering a larger benefit on the outcome you care about.
Ask what a claim means when you see “better absorbed” or “longer lasting” on a label. The study endpoint should match the supplement’s promise.
What MK7 Bone Trials Found
MK7 has meaningful human bone research, including trials with different results.
A three-year trial in 244 healthy postmenopausal women reported less age-related decline in bone mineral density at the lumbar spine and femoral neck with MK7. The same favorable result did not occur at the total hip.
Bone mineral density measures mineral content at a defined site. A change there is relevant, but it does not by itself establish that everyone who uses MK7 will experience fewer fractures.
In a separate three-year trial in 142 postmenopausal women with osteopenia, MK7 improved an osteocalcin marker but did not improve bone density or microarchitecture compared with placebo. Both groups also received calcium and vitamin D.
Together, these studies support a specific conclusion: vitamin K activity and skeletal outcomes are related, but favorable changes in one do not guarantee changes in the other.
How MK4’s Clinical History Differs
MK4 has been studied as menatetrenone in clinical bone research, particularly in Japan.
A 2014 review of eight randomized trials described favorable bone-marker and some skeletal findings in postmenopausal women with osteoporosis who took menatetrenone monotherapy. The research involved defined clinical populations and interventions, not a generic comparison of supermarket supplement bottles.
Those findings do not mean an over-the-counter MK4 product can substitute for osteoporosis care. They also do not establish that MK4 beats MK7 in healthy adults.
Before you rank them via studies, check whether the participants, other treatments, study length, and main outcomes were similar. When they differ, neither form can be called the winner.
Natural vs. Synthetic: Which Is Better?
A supplement’s source and its MK form describe different features. Some MK is synthetically created, while others come from fermented soybeans using Bacillus subtilis natto. Fermentation-derived means bacteria produce the MK7 as they ferment the soybeans, and it is then extracted and purified. That natural origin does not automatically mean better clinical performance.
In randomized studies of specific synthetic and fermentation-derived MK7 preparations, researchers found comparable blood exposure for the tested products. They also examined osteocalcin changes as a marker of vitamin K activity.
This research suggests that scientifically comparing preparations is better than relying on a broad “natural is better” rule. It also does not prove every synthetic and fermented product is equivalent.
Manufacturing quality, identity, and stability are all relevant. Ask whether the manufacturer names the exact form and provides testing relevant to the finished product.
Ask for the batch Certificate of Analysis (COA) and check that it matches the product and batch you buy.
Check the Whole Formula Before Choosing
The complete ingredient list should guide your purchase, even if MK7 is the ingredient that first caught your attention. A single-ingredient comparison cannot stand in for reviewing a blend.
Our BioPurify formula contains vitamin K2 as MK7 alongside nattokinase, red yeast rice, CoQ10, NAC, and other active ingredients. Nattokinase may add to the effect of blood thinners and red yeast rice can act like a statin, so this formula needs the same clinician review described in the next section. See the full ingredient list on the product page.
A combination formula brings several ingredients into one routine. Compare the full label with products you already use, and ask your pharmacist about medication interactions.
- Confirm whether the formula contains MK4, MK7, or both.
- Check every other active ingredient against your medication list.
- Ask for finished-product identity and contaminant testing.
- Keep ingredient research separate from evidence on the finished blend.
For help finding product information, use our supplement FAQs.
Vitamin K and Blood-Thinning Medication
If you are using vitamin K antagonist therapy, let your clinician lead the decision-making. Warfarin and related medicines work through the vitamin K system, so adding a K2 supplement can affect anticoagulation control.
In a controlled study using acenocoumarol in healthy volunteers, supplemental MK7 affected anticoagulation sensitivity. This medication interaction study was not focused on cardiovascular prevention.
If you take warfarin or another vitamin K antagonist, do not start, stop, or switch vitamin K supplements without consulting your prescribing team. Choosing MK4 instead of MK7 does not remove the need for review.
Other blood thinners work differently, but a multi-ingredient blend may bring additional interactions. Bring the complete label to the discussion.
Frequently Asked Questions
These answers focus on what the comparison between MK7 and MK4 can tell you before you buy.
Is MK7 the Same as Vitamin K2?
It can be. MK7 is one form of vitamin K2. MK4 is another, so a label that says only K2 leaves the form unclear.
Is MK7 Better for Bones Than MK4?
There is no universal winner. MK7 has favorable and null human bone trials, while much MK4 research comes from different clinical settings.
Can MK4 and MK7 Be Taken Together?
Some products contain both forms. A combination still needs a clear purpose and medication review, and the presence of both does not prove greater benefit.
Does MK7 Remove Calcium From Arteries?
The role of vitamin K-dependent proteins does not establish that an MK7 supplement removes existing arterial calcium. A supplement should not replace cardiovascular assessment.
Do You Need K2 With Every Vitamin D Product?
Not necessarily. Vitamin D and vitamin K support bone biology, but you do not automatically need a combined supplement. Diet, bone risk, and existing care should guide the decision.
Final Takeaway
Choose the form of vitamin K2 with a clear purpose, a transparent label, and evidence that fits your goal. While MK7’s sustained blood availability is well documented, claims of universal clinical superiority go further than the research supports.
Continue with our beginner’s guide to longevity supplements and check our editorial review standards as you compare options.
Ask a qualified clinician before starting any supplement if you are pregnant, nursing, taking medication, or managing a medical condition.
This article is educational and does not replace medical advice.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
References
- Sato T, Schurgers LJ, Uenishi K. Comparison of menaquinone-4 and menaquinone-7 bioavailability in healthy women. Nutrition Journal. 2012;11:93. PMID 23140417. DOI.
- Knapen MHJ, Drummen NE, Smit E, Vermeer C, Theuwissen E. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporosis International. 2013;24:2499-2507. PMID 23525894. DOI.
- Rønn SH, Harsløf T, Oei L, Pedersen SB, Langdahl BL. The effect of vitamin MK-7 on bone mineral density and microarchitecture in postmenopausal women with osteopenia, a 3-year randomized, placebo-controlled clinical trial. Osteoporosis International. 2021;32:185-191. PMID 33030563. DOI.
- Iwamoto J. Vitamin K2 therapy for postmenopausal osteoporosis. Nutrients. 2014;6(5):1971-1980. PMID 24841104. DOI.
- Møller M, Gjelstad IMF, Baksaas I, Grande T, Aukrust IR, Drevon CA. Bioavailability and chemical/functional aspects of synthetic MK-7 vs fermentation-derived MK-7 in randomised controlled trials. International Journal for Vitamin and Nutrition Research. 2017;87(5-6):297-311. PMID 27374276. DOI.
- Theuwissen E, Teunissen KJ, Spronk HMH, et al. Effect of low-dose supplements of menaquinone-7 (vitamin K2) on the stability of oral anticoagulant treatment: dose-response relationship in healthy volunteers. Journal of Thrombosis and Haemostasis. 2013;11(6):1085-1092. PMID 23530987. DOI.
